BioXcel Therapeutics, Inc. (DUS:BX20) Financings
Financings
| Raise | Date |
|---|---|
| At-the-market programme of common stock Closed: US$11.5M raised | Aug 12, 2025 |
| Warrant exercise of outstanding warrants Closed: US$3.6M raised | Aug 12, 2025 |
| Registered direct offering of shares of common stock (or common stock equivalents) and accompanying warrants Closed: US$14M raised · US$3.5 a share · Warrants at US$4.2 for 60 months · Rodman & Renshaw LLC Dealers: Rodman & Renshaw LLC (lead) Use of proceeds: Working capital and general corporate purposes | Mar 4, 2025 |